Intermittent fasting may protect against liver inflammation and even liver cancer, a new study has found.
The study, conducted at the German Cancer Research Center and the University of Tübingen and published in the journal Cell Metabolism, aimed to understand more about how intermittent fasting can affect the liver. The researchers found that intermittent fasting can halt the progression of non-alcoholic fatty liver disease (NAFLD), a precursor to chronic liver inflammation and liver cancer.
Study Findings Explained
The researchers conducted their experiment by implementing a fasting regimen on mice with preexisting liver inflammation. It was found that after four months of intermittent fasting, the mice had improved liver function tests, less fat in their livers, decreased fibrosis, and were less likely to develop liver cancer in the future.
Ayla Roberts
Author
Ayla Roberts is a registered nurse and freelance writer. She holds both a bachelor's and master's degree in nursing and has worked in a variety of clinical and academic roles.
